Shandong Weigao Orthopaedic Device Co., Ltd Stock
Equities
688161
CNE1000050W9
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.18 CNY | +2.95% |
|
-1.06% | +3.81% |
Capitalization | 10.4B 1.43B 1.37B 1.29B 1.14B 2.03B 124B 2.26B 15.36B 5.7B 51.49B 5.34B 5.24B 218B | P/E ratio 2024 * |
47.6x | P/E ratio 2025 * | 35.9x |
---|---|---|---|---|---|
Enterprise value | 10.4B 1.43B 1.37B 1.29B 1.14B 2.03B 124B 2.26B 15.36B 5.7B 51.49B 5.34B 5.24B 218B | EV / Sales 2024 * |
7.06x | EV / Sales 2025 * | 5.9x |
Free-Float |
10.7% | Yield 2024 * |
0.46% | Yield 2025 * | 0.84% |
1 day | +2.95% | ||
1 week | -1.06% | ||
Current month | +2.39% | ||
1 month | +11.26% | ||
3 months | -14.11% | ||
6 months | +27.03% | ||
Current year | +3.81% |







Director | Title | Age | Since |
---|---|---|---|
Jun Qiang Lu
CEO | Chief Executive Officer | 51 | 2019-09-14 |
Su Yun Lü
DFI | Director of Finance/CFO | 54 | 2023-10-26 |
Rou Zi Chen
HRO | Human Resources Officer | 43 | 2018-07-31 |
Manager | Title | Age | Since |
---|---|---|---|
Jun Qiang Lu
BRD | Director/Board Member | 51 | 2018-08-31 |
Rui Jie Zhang
BRD | Director/Board Member | 55 | 2020-03-25 |
Guo Xia Qu
BRD | Director/Board Member | 61 | 2020-03-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.28% | 2 M€ | +1.17% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+2.95% | -1.06% | -14.61% | -53.30% | 1.39B | ||
-0.01% | +0.01% | +44.42% | +119.97% | 12.57B | ||
-0.64% | +4.57% | +1.59% | +23.25% | 10.47B | ||
+0.18% | +2.69% | +36.38% | -19.45% | 9.62B | ||
+0.86% | -0.05% | +6.93% | -40.24% | 5.32B | ||
-1.00% | +0.68% | +19.56% | +188.49% | 4.99B | ||
+1.61% | -0.19% | -0.61% | +20.68% | 4.95B | ||
+0.03% | +0.25% | +37.29% | +5.71% | 4.69B | ||
-0.80% | +0.10% | -12.72% | +38.55% | 4.56B | ||
+4.03% | +0.27% | +42.83% | -71.72% | 2.35B | ||
Average | +0.65% | -0.08% | +16.11% | +21.19% | 6.09B | |
Weighted average by Cap. | +0.21% | +0.57% | +20.59% | +38.65% |
2024 * | 2025 * | |
---|---|---|
Net sales | 1.47B 202M 194M 183M 161M 287M 17.53B 321M 2.18B 808M 7.3B 757M 742M 30.91B | 1.76B 242M 231M 219M 193M 343M 20.95B 383M 2.6B 965M 8.72B 905M 887M 36.95B |
Net income | 222M 30.44M 29.15M 27.53M 24.28M 43.27M 2.64B 48.31M 328M 122M 1.1B 114M 112M 4.66B | 292M 40.04M 38.34M 36.21M 31.93M 56.92M 3.47B 63.54M 431M 160M 1.45B 150M 147M 6.12B |
Net Debt | - | - |
Date | Price | Change | Volume |
---|---|---|---|
25-02-13 | 26.18 ¥ | +2.95% | 1,719,950 |
25-02-13 | 25.43 ¥ | -1.43% | 859,086 |
25-02-12 | 25.80 ¥ | +0.27% | 1,106,555 |
25-02-11 | 25.73 ¥ | -2.17% | 1,225,497 |
25-02-10 | 26.30 ¥ | +0.31% | 1,320,017 |
End-of-day quote Shanghai S.E., February 13, 2025
More quotes
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688161 Stock